Fang CT - Search Results

1

Special issue: Taiwan model against COVID-19.

Chang SC, Fang CT. Chang SC, et al. Among authors: fang ct. J Formos Med Assoc. 2024 Jan;123 Suppl 1:S1. doi: 10.1016/j.jfma.2024.01.002. Epub 2024 Jan 3. J Formos Med Assoc. 2024. PMID: 38177054 Free article. No abstract available.

2

Clinical manifestations, microbiology and prognosis of 42 patients with necrotizing fasciitis.

Hung CC, Chang SC, Lin SF, Fang CT, Chen YC, Hsieh WC. Hung CC, et al. Among authors: fang ct. J Formos Med Assoc. 1996 Dec;95(12):917-22. J Formos Med Assoc. 1996. PMID: 9000808

3

Fusarium solani fungemia in a bone marrow transplant recipient.

Fang CT, Chang SC, Tang IL, Hsueh PR, Chang YL, Hung CC, Chen YC. Fang CT, et al. J Formos Med Assoc. 1997 Feb;96(2):129-33. J Formos Med Assoc. 1997. PMID: 9071840

4

Life-threatening scrub typhus with meningoencephalitis and acute respiratory distress syndrome.

Fang CT, Ferng WF, Hwang JJ, Yu CJ, Chen YC, Wang MH, Chang SC, Hsieh WC. Fang CT, et al. J Formos Med Assoc. 1997 Mar;96(3):213-6. J Formos Med Assoc. 1997. PMID: 9080762

5

Haemophilus aphrophilus bacteraemia complicated with vertebral osteomyelitis and spinal epidural abscess in a patient with liver cirrhosis.

Hung CC, Hsueh PR, Chen YC, Fang CT, Chang SC, Luh KT, Hsieh WC. Hung CC, et al. Among authors: fang ct. J Infect. 1997 Nov;35(3):304-8. doi: 10.1016/s0163-4453(97)93422-8. J Infect. 1997. PMID: 9459409

6

Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: in comparison with ceftazidime treatment.

Chang SC, Fang CT, Hsueh PR, Liu CJ, Sheng WH, Hsieh SM, Hung CC, Chen YC. Chang SC, et al. Among authors: fang ct. Int J Antimicrob Agents. 1998 Aug;10(3):245-8. doi: 10.1016/s0924-8579(98)00040-5. Int J Antimicrob Agents. 1998. PMID: 9832286 Clinical Trial.

7

In vitro activity of meropenem against common pathogenic bacteria isolated in Taiwan.

Chang SC, Fang CT, Chen YC, Hsueh PR, Luh KT, Hsieh WC. Chang SC, et al. Among authors: fang ct. Diagn Microbiol Infect Dis. 1998 Dec;32(4):273-9. doi: 10.1016/s0732-8893(98)00111-4. Diagn Microbiol Infect Dis. 1998. PMID: 9934544

8

In vitro activity of quinupristin/dalfopristin against clinical isolates of common gram-positive bacteria in Taiwan.

Chang SC, Fang CT, Hsueh PR, Luh KT, Hsieh WC. Chang SC, et al. Among authors: fang ct. Diagn Microbiol Infect Dis. 1999 Apr;33(4):299-303. doi: 10.1016/s0732-8893(98)00147-3. Diagn Microbiol Infect Dis. 1999. PMID: 10212757

9

Successful treatment of disseminated Mycobacterium szulgai infection with ciprofloxacin, rifampicin, and ethambutol.

Fang CT, Chang SC, Luh KT, Chang YL, Hsueh PR, Hsieh WC. Fang CT, et al. J Infect. 1999 May;38(3):195-7. doi: 10.1016/s0163-4453(99)90252-9. J Infect. 1999. PMID: 10424803 Review. No abstract available.

10

From effect size into number needed to treat.

Fang CT, Sau WY, Chang SC. Fang CT, et al. Lancet. 1999 Aug 14;354(9178):597-8. doi: 10.1016/S0140-6736(05)77951-4. Lancet. 1999. PMID: 10470727 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page